In a move to enhance its diabetes portfolio in India, Indianapolis, Indiana-based Eli Lilly launched a once-a-week diabetes treatment drug under the brand name Trulicity, a glucagon-like peptide-1 (GLP-1) receptor agonist, a hormone that helps normalize blood sugar levels in those with Type 2 diabetes, reports BusinessLine. Priced at $37.15,...